A thiazolamine that inhibits LTB4 synthesis in human neutrophils (IC<sub>50</sub> = ~0.5 µM) and conversion of LTA4 to LTB4 by purified LTA4 hydrolase (Ki = 2.
A thiazolamine that inhibits LTB4 synthesis in human neutrophils (IC<sub>50</sub> = ~0.5 µM) and conversion of LTA4 to LTB4 by purified LTA4 hydrolase (Ki = 2.